BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37548777)

  • 1. Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells.
    Hedayat M; Khezri MR; Jafari R; Malekinejad H; Majidi Zolbanin N
    Med Oncol; 2023 Aug; 40(9):263. PubMed ID: 37548777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Bakhshi A; Abazari O; Abbasi M; Khanicheragh P; Shabanzadeh M
    Gene; 2021 Jun; 787():145638. PubMed ID: 33848578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic enhancement of apoptosis by coralyne and paclitaxel in combination on MDA-MB-231 a triple-negative breast cancer cell line.
    Kumari S; Mohan MG; Shailender G; Badana AK; Malla RR
    J Cell Biochem; 2019 Oct; 120(10):18104-18116. PubMed ID: 31172606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468.
    Natarajan S; Ranganathan M
    Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine counteracts the effects of paclitaxel in triple-negative breast cancer cells.
    Sezer G; Caner A; Önal MG; Cumaoğlu A
    Indian J Med Res; 2022 Jul; 156(1):70-76. PubMed ID: 36510900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
    Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS
    Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2017 Mar; 50(3):893-902. PubMed ID: 28197640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-26a-5p Heightens Breast Cancer Cell Sensitivity to Paclitaxel via Targeting Flap Endonuclease 1.
    Cai Y; Zhang T; Chen G; Liu C
    Ann Clin Lab Sci; 2023 Jan; 53(1):116-125. PubMed ID: 36889769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line.
    Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E
    Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D enhances the sensitivity of breast cancer cells to the combination therapy of photodynamic therapy and paclitaxel.
    Liu X; Lv H; Shen H
    Tissue Cell; 2022 Aug; 77():101815. PubMed ID: 35623307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition.
    Morales-Cano D; Calviño E; Rubio V; Herráez A; Sancho P; Tejedor MC; Diez JC
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):1101-8. PubMed ID: 23735541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
    Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
    Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
    Li G; Xu D; Sun J; Zhao S; Zheng D
    Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
    Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
    J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines.
    Ye J; Xia X; Dong W; Hao H; Meng L; Yang Y; Wang R; Lyu Y; Liu Y
    Int J Nanomedicine; 2016; 11():4125-40. PubMed ID: 27601899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celecoxib induced apoptosis against different breast cancer cell lines by down-regulated NF-κB pathway.
    Wang G; Li J; Zhang L; Huang S; Zhao X; Zhao X
    Biochem Biophys Res Commun; 2017 Aug; 490(3):969-976. PubMed ID: 28666869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy.
    Liu Y; Hong G; Mao L; Su Z; Liu T; Liu H
    Molecules; 2023 Apr; 28(9):. PubMed ID: 37175072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-18a upregulation decreases Dicer expression and confers paclitaxel resistance in triple negative breast cancer.
    Sha LY; Zhang Y; Wang W; Sui X; Liu SK; Wang T; Zhang H
    Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2201-8. PubMed ID: 27338043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.